Investor Relations - Achieve Life Sciences - Investor Alerts

HOME
ABOUT ACHIEVE
PRODUCTS
- Cytisinicline
NEWS
INVESTORS
CONTACT

HOME
ABOUT ACHIEVE
- About Achieve
- Senior Management
PRODUCTS
- Cytisinicline
NEWS
INVESTORS
CONTACT

Investor Alerts

Home / Investor Alerts

Home ivps4 2017-06-16T21:39:52+00:00

Investors Home
Corporate Governance
News Releases
Financial Information
SEC Filings
Events and Webcasts
Investor Contacts
Investor Alerts

RSS

NASDAQ: ACHV NASDAQ: OGXI

Enter the email address that you used to subscribe to this list.

Email

NASDAQ: ACHV NASDAQ: OGXI

1dy

1mo

6mo

1yr

5yr

Stock Info

NASDAQ: ACHV NASDAQ: OGXI

Achieve Life Sciences US Headquarters

520 Pike Street, Suite 2250
Seattle, WA 98101
Phone: (425) 686-1500

Email: info@achievelifesciences.com

Vancouver – Principal Executive Office

1001 W. Broadway, Suite 400
Vancouver, BC V6H 4B1
Phone: (604) 736-3678

Email: info@achievelifesciences.com

About Achieve

About Achieve
Senior Management
Board of Directors
Cytisinicline
Contact

For Investors

Investors
News
Corporate Governance
Financial Information
SEC Filings
Investor Alerts

Recent News

Investor Alerts

Nov 7, 2018

Achieve Reports Financial Results for Third Quarter 2018 and Provides Cytisinicline (Cytisine) Clinical Development Update

Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today provided...

© Copyright 2016 - | Achieve Life Sciences, Inc. All Rights Reserved | Privacy Policy | Disclaimer | Contact Us